Shalby Share Price
Sector: Healthcare Facilities
201.50 +1.80 (0.90%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
198.00
Today’s High
205.60
52 Week Low
177.25
52 Week High
325.00
201.78 +1.86 (0.93%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
197.86
Today’s High
205.80
52 Week Low
177.45
52 Week High
325.00
Key Metrics
- Market Cap (In Cr) 2166.05
- Beta 0.95
- Div. Yield (%) 0.6
- P/B 2.15
- TTM P/E 77.41
- Peg Ratio 2.6
- Sector P/E 22.82
- Open Price 198.75
- Prev Close 199.7
Shalby Analysis
Price Analysis
-
1 Week4.8%
-
3 Months0.83%
-
6 Month-6.55%
-
YTD-12.95%
-
1 Year-27.85%
Risk Meter
- 36% Low risk
- 36% Moderate risk
- 36% Balanced Risk
- 36% High risk
- 36% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 0.00
- 0.00
- 0.00
- 0.00
- Buy
- 1
- 1
- 1
- 1
- Hold
- 0.00
- 0.00
- 0.00
- 0.00
- Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 1
- 1
- 1
- 1
Shalby News
Stocks to Watch: Adani Ent, HUDCO, Maruti Suzuki, Cipla, Canara Bank, and more
5 min read . 30 Oct 2024Stocks to buy or sell: Sumeet Bagadia recommends five breakout stocks
2 min read . 08 Jul 2024Shalby Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 933.95
- Selling/ General/ Admin Expenses Total
- 248.41
- Depreciation/ Amortization
- 52.24
- Other Operating Expenses Total
- 1.03
- Total Operating Expense
- 806.92
- Operating Income
- 127.03
- Net Income Before Taxes
- 128.19
- Net Income
- 84.08
- Diluted Normalized EPS
- 7.82
- Period
- 2024
- Total Assets
- 1607.53
- Total Liabilities
- 607.16
- Total Equity
- 1000.37
- Tangible Book Valueper Share Common Eq
- 86.15
- Period
- 2024
- Cashfrom Operating Activities
- 127.56
- Cashfrom Investing Activities
- 38.07
- Cashfrom Financing Activities
- -150.69
- Net Changein Cash
- 14.94
- Period
- 2023
- Total Revenue
- 804.92
- Selling/ General/ Admin Expenses Total
- 228.05
- Depreciation/ Amortization
- 48.09
- Other Operating Expenses Total
- 1.08
- Total Operating Expense
- 712.33
- Operating Income
- 92.6
- Net Income Before Taxes
- 102.04
- Net Income
- 67.7
- Diluted Normalized EPS
- 6.31
- Period
- 2023
- Total Assets
- 1281.36
- Total Liabilities
- 353.68
- Total Equity
- 927.69
- Tangible Book Valueper Share Common Eq
- 84.44
- Period
- 2023
- Cashfrom Operating Activities
- 67.79
- Cashfrom Investing Activities
- -61.08
- Cashfrom Financing Activities
- -50.02
- Net Changein Cash
- -43.31
- Period
- 2022
- Total Revenue
- 698.94
- Selling/ General/ Admin Expenses Total
- 345.71
- Depreciation/ Amortization
- 42.87
- Other Operating Expenses Total
- 190.08
- Total Operating Expense
- 625.2
- Operating Income
- 73.75
- Net Income Before Taxes
- 79.15
- Net Income
- 54.13
- Diluted Normalized EPS
- 5.32
- Period
- 2022
- Total Assets
- 1193.54
- Total Liabilities
- 317.22
- Total Equity
- 876.32
- Tangible Book Valueper Share Common Eq
- 79.19
- Period
- 2022
- Cashfrom Operating Activities
- 18.92
- Cashfrom Investing Activities
- -60.28
- Cashfrom Financing Activities
- 90.46
- Net Changein Cash
- 49.1
- Period
- 2021
- Total Revenue
- 430.9
- Selling/ General/ Admin Expenses Total
- 190.58
- Depreciation/ Amortization
- 36.8
- Other Operating Expenses Total
- 46.55
- Total Operating Expense
- 377.64
- Operating Income
- 53.26
- Net Income Before Taxes
- 55.05
- Net Income
- 42.4
- Diluted Normalized EPS
- 4.14
- Period
- 2021
- Total Assets
- 996.62
- Total Liabilities
- 161.97
- Total Equity
- 834.65
- Tangible Book Valueper Share Common Eq
- 75.69
- Period
- 2021
- Cashfrom Operating Activities
- 79.15
- Cashfrom Investing Activities
- -51.27
- Cashfrom Financing Activities
- -29.86
- Net Changein Cash
- -1.98
- Period
- 2020
- Total Revenue
- 486.85
- Selling/ General/ Admin Expenses Total
- 232.9
- Depreciation/ Amortization
- 36.02
- Other Operating Expenses Total
- 46.47
- Total Operating Expense
- 440.39
- Operating Income
- 46.46
- Net Income Before Taxes
- 56.73
- Net Income
- 27.59
- Diluted Normalized EPS
- 2.56
- Period
- 2020
- Total Assets
- 966.63
- Total Liabilities
- 167.46
- Total Equity
- 799.17
- Tangible Book Valueper Share Common Eq
- 72.67
- Period
- 2020
- Cashfrom Operating Activities
- 55.37
- Cashfrom Investing Activities
- -30.67
- Cashfrom Financing Activities
- -21.5
- Net Changein Cash
- 3.21
- Period
- 2019
- Total Revenue
- 462.26
- Selling/ General/ Admin Expenses Total
- 219.39
- Depreciation/ Amortization
- 33.17
- Other Operating Expenses Total
- 47.58
- Total Operating Expense
- 412.45
- Operating Income
- 49.81
- Net Income Before Taxes
- 50.39
- Net Income
- 31.66
- Diluted Normalized EPS
- 2.93
- Period
- 2019
- Total Assets
- 939.16
- Total Liabilities
- 159.37
- Total Equity
- 779.79
- Tangible Book Valueper Share Common Eq
- 71.07
- Period
- 2019
- Cashfrom Operating Activities
- 43.4
- Cashfrom Investing Activities
- 1.39
- Cashfrom Financing Activities
- -51.25
- Net Changein Cash
- -6.45
- Period
- 2024-12-31
- Total Revenue
- 275.63
- Selling/ General/ Admin Expenses Total
- 47.82
- Depreciation/ Amortization
- 16.32
- Other Operating Expenses Total
- 40.69
- Total Operating Expense
- 258.04
- Operating Income
- 17.59
- Net Income Before Taxes
- 12.35
- Net Income
- -1.81
- Diluted Normalized EPS
- -0.28
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 267.54
- Selling/ General/ Admin Expenses Total
- 47.11
- Depreciation/ Amortization
- 16.84
- Other Operating Expenses Total
- 33.64
- Total Operating Expense
- 251.73
- Operating Income
- 15.81
- Net Income Before Taxes
- 13.7
- Net Income
- 3.39
- Diluted Normalized EPS
- 0.32
- Period
- 2024-09-30
- Total Assets
- 1716.61
- Total Liabilities
- 709.99
- Total Equity
- 1006.61
- Tangible Book Valueper Share Common Eq
- 86.6
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 11.46
- Cashfrom Investing Activities
- -57.06
- Cashfrom Financing Activities
- 55.18
- Net Changein Cash
- 9.57
- Period
- 2024-06-30
- Total Revenue
- 278.89
- Selling/ General/ Admin Expenses Total
- 44.85
- Depreciation/ Amortization
- 16.37
- Other Operating Expenses Total
- 26.79
- Total Operating Expense
- 250.05
- Operating Income
- 28.84
- Net Income Before Taxes
- 30.41
- Net Income
- 15.66
- Diluted Normalized EPS
- 1.38
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 244.43
- Selling/ General/ Admin Expenses Total
- 39.93
- Depreciation/ Amortization
- 15.6
- Other Operating Expenses Total
- 29.94
- Total Operating Expense
- 221.17
- Operating Income
- 23.26
- Net Income Before Taxes
- 21.78
- Net Income
- 16.6
- Diluted Normalized EPS
- 1.55
- Period
- 2024-03-31
- Total Assets
- 1607.53
- Total Liabilities
- 607.16
- Total Equity
- 1000.37
- Tangible Book Valueper Share Common Eq
- 86.15
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 127.56
- Cashfrom Investing Activities
- 38.07
- Cashfrom Financing Activities
- -150.69
- Net Changein Cash
- 14.94
- Period
- 2023-12-31
- Total Revenue
- 216.05
- Selling/ General/ Admin Expenses Total
- 37.76
- Depreciation/ Amortization
- 12.4
- Other Operating Expenses Total
- 18.94
- Total Operating Expense
- 186.12
- Operating Income
- 29.93
- Net Income Before Taxes
- 30.81
- Net Income
- 19.07
- Diluted Normalized EPS
- 1.78
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Shalby Technical
Moving Average
SMA
- 5 Day194.39
- 10 Day188.39
- 20 Day190.59
- 50 Day194.96
- 100 Day206.72
- 300 Day231.98
Shalby Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Indraprastha Medical Corp
- 421
- 3.25
- 0.78
- 571.95
- 212.25
- 3870.63
- Artemis Medicare Services
- 249.85
- -0.95
- -0.38
- 348.3
- 144.5
- 3456.38
- Shalby
- 201.5
- 1.8
- 0.9
- 325
- 177.25
- 2166.05
- Krsnaa Diagnostics
- 643.05
- 9.15
- 1.44
- 1041.8
- 527.55
- 2076.39
- Dr. Agarwal's Eye Hospital
- 4370
- -27.9
- -0.63
- 7300
- 2800
- 2054.22
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Indraprastha Medical Corp
- 31.71
- 8.29
- 19.59
- 6.73
- Artemis Medicare Services
- 46.48
- 4.05
- 9.91
- 5.88
- Shalby
- 25.45
- 2.14
- 6.37
- 8.2
- Krsnaa Diagnostics
- 27.59
- 2.38
- 16.02
- 16.81
- Dr. Agarwal's Eye Hospital
- 43.19
- 12.79
- 29.64
- 10.83
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 03-Feb-25
- Quarterly Results & Others
- 30-Oct-24
- Quarterly Results
- 08-Jul-24
- Quarterly Results
- 28-May-24
- Audited Results & Final Dividend
- 07-Feb-24
- Quarterly Results
- 27-Oct-23
- Quarterly Results
- 20-Jul-23
- Quarterly Results
- 18-May-23
- Audited Results & Final Dividend
- 15-May-23
- Audited Results & Final Dividend
- 17-Jan-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 16-Mar-25
- 10-Feb-25
- POM
- 26-Sept-24
- 23-Aug-24
- AGM
- 20-Aug-23
- 13-Jul-23
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 28-May-24
- -
- 19-Sept-24
- 1.2
- 18-May-23
- -
- 08-Aug-23
- 1.2
- 25-May-22
- -
- 19-Sept-22
- 1
- 05-May-21
- -
- 17-Sept-21
- 1


